Lung cancer sufferers are to be given an expensive life-prolonging drug on the NHS under a deal with manufacturers to cut the medication's price.
tags: Health Service Economics, Financial Management, Lung Cancer, Drug Therapy, NHS, Health, News, UHN, The Telegraph
No comments:
Post a Comment